SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE)

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COMMON STOCK
Total 13F shares
28,113,883
Share change
+5,745,551
Total reported value
$75,058,304
Put/Call ratio
142%
Price per share
$2.67
Number of holders
77
Value change
+$15,035,647
Number of buys
40
Number of sells
23

Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q2 2019

As of 30 Jun 2019, SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,113,883 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), GEODE CAPITAL MANAGEMENT, LLC, CVI Holdings, LLC, NORTHERN TRUST CORP, Hudson Bay Capital Management LP, Bank of New York Mellon Corp, and NUVEEN ASSET MANAGEMENT, LLC. This page lists 77 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.